Zobrazeno 1 - 10
of 121
pro vyhledávání: '"Yi Lisa Hwa"'
Autor:
Eli Muchtar, Matthew T. Drake, Nelson Leung, Angela Dispenzieri, Martha Q. Lacy, Francis K. Buadi, David Dingli, Suzanne R. Hayman, Prashant Kapoor, Yi Lisa Hwa, Amie Fonder, Miriam Hobbs, Wilson Gonsalves, Taxiarchis V. Kourelis, Rahma Warsame, Stephen Russell, Ronald S. Go, Moritz Binder, Robert A. Kyle, S. Vincent Rajkumar, Shaji K. Kumar, Morie A. Gertz
Publikováno v:
Frontiers in Endocrinology, Vol 13 (2022)
IntroductionVitamin D deficiency is common, but no data have been reported on vitamin D levels in light chain (AL) amyloidosis.Patients and MethodsIn this exploratory study, stored serum samples from 173 patients with newly diagnosed AL amyloidosis w
Externí odkaz:
https://doaj.org/article/ba524f74cc864fed94a7e7acb5a37633
Autor:
Arjun Lakshman, Utkarsh Painuly, S. Vincent Rajkumar, Rhett P. Ketterling, Prashant Kapoor, Patricia T. Greipp, Angela Dispenzieri, Morie A. Gertz, Francis K. Buadi, Martha Q. Lacy, David Dingli, Amie L. Fonder, Suzanne R. Hayman, Miriam A. Hobbs, Wilson I. Gonsalves, Yi Lisa Hwa, Nelson Leung, Ronald S. Go, Yi Lin, Taxiarchis V. Kourelis, Rahma Warsame, John A. Lust, Stephen J. Russell, Steven R. Zeldenrust, Robert A. Kyle, Shaji K. Kumar
Publikováno v:
Blood Advances, Vol 3, Iss 13, Pp 1930-1938 (2019)
Abstract: The high-risk abnormality del(17p) can be detected by fluorescence in situ hybridization on malignant plasma cells (PCs) and has an adverse prognostic impact in patients with multiple myeloma (MM). Patients with del(17p) have reduced overal
Externí odkaz:
https://doaj.org/article/a708625245944f65affeb4fc31fd1ac8
Autor:
Sarah Goldman-Mazur, Alissa Visram, Prashant Kapoor, Angela Dispenzieri, Martha Q. Lacy, Morie A. Gertz, Francis K. Buadi, Suzanne R. Hayman, David Dingli, Taxiarchis Kourelis, Wilson Gonsalves, Rahma Warsame, Eli Muchtar, Nelson Leung, Moritz Binder, Amie Fonder, Miriam Hobbs, Yi Lisa Hwa, Robert A. Kyle, S. Vincent Rajkumar, Shaji K. Kumar
Publikováno v:
Blood Advances. 7:909-917
Almost all patients with multiple myeloma (MM) eventually relapse, either asymptomatically or with end-organ damage. However, it remains unclear whether initiating therapy at the time of biochemical progression (BP) improves the outcomes compared wit
Autor:
Bharat Nandakumar, Francis Baffour, Nadine H. Abdallah, Shaji K. Kumar, Angela Dispenzieri, Francis K. Buadi, David Dingli, Martha Q. Lacy, Suzanne R. Hayman, Prashant Kapoor, Nelson Leung, Amie Fonder, Miriam Hobbs, Yi Lisa Hwa, Eli Muchtar, Rahma Warsame, Taxiarchis V. Kourelis, Ronald S. Go, Robert A. Kyle, Morie A. Gertz, S. Vincent Rajkumar, Jason Klug, Panagiotis Korfiatis, Wilson I. Gonsalves
Publikováno v:
Cancer. 129:385-392
Sarcopenia increases with age and is associated with poor survival outcomes in patients with cancer. By using a deep learning-based segmentation approach, clinical computed tomography (CT) images of the abdomen of patients with newly diagnosed multip
Autor:
Eli Muchtar, Morie A. Gertz, Betsy R. LaPlant, Francis K. Buadi, Nelson Leung, Patrick O’Brien, P. Leif Bergsagel, Amie Fonder, Yi Lisa Hwa, Miriam Hobbs, Dania K. Helgeson, Erin E. Bradt, Wilson Gonsalves, Martha Q. Lacy, Prashant Kapoor, Mustaqueem Siddiqui, Jeremy T. Larsen, Rahma Warsame, Suzanne R. Hayman, Ronald S. Go, David Dingli, Taxiarchis V. Kourelis, Angela Dispenzieri, S. Vincent Rajkumar, Shaji K. Kumar
Publikováno v:
Blood Advances. 6:5429-5435
Bortezomib, a proteasome inhibitor (PI), has shown efficacy in the treatment of newly diagnosed and relapsed light chain (AL) amyloidosis, and is often used in combination with cyclophosphamide and dexamethasone. Ixazomib is the first oral PI to be a
Autor:
David Dingli, Francis K. Buadi, Linda B. Baughn, Yi Lisa Hwa, Wilson I. Gonsalves, Shaji Kumar, Rahma Warsame, Morie A. Gertz, Yi Lin, Angela Dispenzieri, Joselle Cook, Mustaqeem A. Siddiqui, Patricia T. Greipp, Eli Muchtar, Hadiyah Y. Audil, Miriam Hobbs, Taxiarchis Kourelis, Martha Q. Lacy, Prashant Kapoor, Suzanne R. Hayman, S. Vincent Rajkumar, Amie Fonder, Robert A. Kyle, Nelson Leung, Rhett P. Ketterling
Publikováno v:
American Journal of Hematology. 97:52-59
Gain of 1q22 at diagnosis portends poorer outcomes in multiple myeloma (MM), but the prognostic significance of acquired 1q22 gain is unknown. We identified 63 MM patients seen at Mayo Clinic from 1/2004 to 12/2019 without 1q22 gain at diagnosis who
Autor:
Morie A. Gertz, Yi Lisa Hwa, Stephen J. Russell, David Dingli, Taxiarchis Kourelis, Wilson I. Gonsalves, Shaji Kumar, Eli Muchtar, Robert A. Kyle, Rahma Warsame, Francis K. Buadi, Mustaqeem A. Siddiqui, Nelson Leung, Prashant Kapoor, Suzanne R. Hayman, Amie Fonder, Moritz Binder, S. Vincent Rajkumar, Miriam Hobbs, Yi Lin, Martha Q. Lacy, Bharat Nandakumar, Angela Dispenzieri
Publikováno v:
Leukemia. 36:801-808
Background: There has been a steady improvement in the survival of patients with multiple myeloma (MM) due to better understanding of the pathophysiology, use of novel agents, and risk-adapted therapy. These improvements were largely observed in clin
Autor:
Jean-Sébastien Claveau, David L. Murray, Angela Dispenzieri, Prashant Kapoor, Moritz Binder, Francis Buadi, David Dingli, Amie Fonder, Morie Gertz, Wilson Gonsalves, Suzanne Hayman, Miriam Hobbs, Yi Lisa Hwa, Taxiarchis Kourelis, Martha Lacy, Nelson Leung, Yi Lin, Rahma Warsame, Robert A. Kyle, Vincent Rajkumar, Shaji K. Kumar
Publikováno v:
Leukemia.
Autor:
Robert A. Kyle, Miriam Hobbs, A L Fonder, Eli Muchtar, Shaji Kumar, Prashant Kapoor, Iuliana Vaxman, Nelson Leung, Mustaqueem Siddiqui, S V Rajkumar, Ronald S. Go, D. Dingli, Martha Q. Lacy, Morie A. Gertz, Wilson I. Gonsalves, S.R. Hayman, Taxiarchis Kourelis, Yi Lisa Hwa, Rahma Warsame, Yi Lin, Francis K. Buadi, Martha Grogan, Angela Dispenzieri
Publikováno v:
Leukemia
Autor:
Taxiarchis Kourelis, John A. Lust, Amie Fonder, Wilson I. Gonsalves, Martha Q. Lacy, Rahma Warsame, Angela Dispenzieri, Nelson Leung, Mustaqeem A. Siddiqui, Robert A. Kyle, Prashant Kapoor, Bharat Nandakumar, Ronald S. Go, Shaji Kumar, Yi Lisa Hwa, David Dingli, Suzanne R. Hayman, S. Vincent Rajkumar, Eli Muchtar, Francis K. Buadi, Miriam Hobbs, Morie A. Gertz, Yi Lin, Stephen J. Russell, Dragan Jevremovic
Publikováno v:
Mayo Clin Proc
Objective To evaluate the clinical outcomes of patients with primary plasma cell leukemia (pPCL) defined by 5% or greater clonal circulating plasma cells on peripheral blood smear and treated with novel agent induction therapies. Patients and Methods